Structures by: Cui M.
Total: 35
C14H13IO2
C14H13IO2
Journal of medicinal chemistry (2014) 57, 14 6030-6042
a=7.8201(6)Å b=15.7081(11)Å c=21.1791(15)Å
α=90.00° β=90.00° γ=90.00°
C14H13IO2
C14H13IO2
Journal of medicinal chemistry (2014) 57, 14 6030-6042
a=6.1079(12)Å b=7.2239(14)Å c=28.327(5)Å
α=90.00° β=90.00° γ=90.00°
C21H25FNO2.5
C21H25FNO2.5
Journal of medicinal chemistry (2013) 56, 9 3478-3491
a=21.457(10)Å b=5.787(3)Å c=29.727(15)Å
α=90.00° β=98.372(15)° γ=90.00°
C28H33N3NaO10ReS
C28H33N3NaO10ReS
Molecular pharmaceutics (2015) 12, 8 2937-2946
a=31.609(3)Å b=10.4939(11)Å c=9.2829(10)Å
α=90.00° β=96.146(2)° γ=90.00°
C18H15N3
C18H15N3
Journal of medicinal chemistry (2015) 58, 17 6972-6983
a=15.885(4)Å b=7.4464(16)Å c=25.627(6)Å
α=90.00° β=104.762(4)° γ=90.00°
C20H17N3
C20H17N3
Journal of medicinal chemistry (2015) 58, 17 6972-6983
a=17.171(5)Å b=7.611(2)Å c=25.394(8)Å
α=90.00° β=95.737(4)° γ=90.00°
C34H36Ag2Cl2N4O8
C34H36Ag2Cl2N4O8
RSC Advances (2020) 10, 65 39359-39365
a=13.2192(7)Å b=10.7130(5)Å c=13.2447(7)Å
α=90° β=112.909(2)° γ=90°
C34H36Ag2Cl2N4O8
C34H36Ag2Cl2N4O8
RSC Advances (2020) 10, 65 39359-39365
a=13.1734(7)Å b=10.6736(6)Å c=13.2327(7)Å
α=90° β=112.887(2)° γ=90°
C15H11NO4S
C15H11NO4S
Organic & biomolecular chemistry (2017) 15, 3 536-540
a=10.8402(18)Å b=10.9776(18)Å c=11.4168(19)Å
α=90° β=90° γ=90°
C47H36EuF9N2O6
C47H36EuF9N2O6
Dalton Transactions (2020)
a=10.6976(9)Å b=10.7310(6)Å c=11.1962(9)Å
α=83.744(5)° β=66.703(8)° γ=73.668(6)°
C47H36EuF9N2O6
C47H36EuF9N2O6
Dalton Transactions (2020)
a=10.7349(3)Å b=10.7689(2)Å c=11.1509(4)Å
α=83.873(2)° β=66.744(3)° γ=74.512(2)°
C47H36F9N2O6Sm
C47H36F9N2O6Sm
Dalton Transactions (2020)
a=10.7328(4)Å b=10.7633(4)Å c=11.2076(4)Å
α=83.741(3)° β=66.691(4)° γ=73.880(4)°
C47H36F9N2O6Sm
C47H36F9N2O6Sm
Dalton Transactions (2020)
a=10.6922(7)Å b=10.7184(9)Å c=11.1514(8)Å
α=83.872(7)° β=66.808(6)° γ=74.017(7)°
C22H20BF2N3O
C22H20BF2N3O
Chemical communications (Cambridge, England) (2020) 56, 53 7269-7272
a=7.9478(6)Å b=8.3539(5)Å c=14.6488(10)Å
α=74.878(6)° β=76.982(6)° γ=83.501(6)°
C17H16O2
C17H16O2
Chemical Communications (2019)
a=18.085(4)Å b=9.7655(19)Å c=17.955(4)Å
α=90° β=115.852(15)° γ=90°
CoO6Te,4(Na)
CoO6Te,4(Na)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 15 5076-5081
a=5.677(5)Å b=9.524(7)Å c=5.485(4)Å
α=90.00° β=109.470(14)° γ=90.00°
NiO6Te,4(Na)
NiO6Te,4(Na)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 15 5076-5081
a=5.405(2)Å b=5.668(2)Å c=9.565(5)Å
α=73.026(8)° β=89.644(17)° γ=80.439(12)°
Br2Cu5O16P4,12(HO0.50),2(Sr)
Br2Cu5O16P4,12(HO0.50),2(Sr)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 13 4461-4466
a=9.6799(6)Å b=9.6799(6)Å c=12.5073(9)Å
α=90° β=90° γ=90°
Cl2Cu5O16P4,8(O),2(Sr)
Cl2Cu5O16P4,8(O),2(Sr)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 13 4461-4466
a=9.632(4)Å b=9.632(4)Å c=12.464(5)Å
α=90° β=90° γ=90°
H4KNaO11V4
H4KNaO11V4
Dalton transactions (Cambridge, England : 2003) (2016) 45, 12 5234-5239
a=8.257(8)Å b=15.475(16)Å c=8.373(8)Å
α=90.00° β=90.455(17)° γ=90.00°
BaCo4O18P4
BaCo4O18P4
Dalton transactions (Cambridge, England : 2003) (2016) 45, 21 8708-8711
a=18.453(2)Å b=8.3383(9)Å c=9.4995(13)Å
α=90.00° β=90.00° γ=90.00°
BaCu2H2O9P2
BaCu2H2O9P2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 8 3319-3326
a=5.163(2)Å b=9.730(4)Å c=14.574(6)Å
α=90.00° β=90.00° γ=90.00°
BaCu0.5O4.5P
BaCu0.5O4.5P
Dalton transactions (Cambridge, England : 2003) (2016) 45, 8 3319-3326
a=8.328(6)Å b=5.868(4)Å c=9.078(6)Å
α=90.00° β=112.571(10)° γ=90.00°
HMnO9Pb2V2
HMnO9Pb2V2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 16 7022-7027
a=7.672(7)Å b=6.168(5)Å c=8.781(9)Å
α=90.00° β=111.232(14)° γ=90.00°
C30H30Cl2N3O5ReS
C30H30Cl2N3O5ReS
Dalton transactions (Cambridge, England : 2003) (2015) 44, 14 6406-6415
a=7.8257(13)Å b=13.264(2)Å c=15.137(3)Å
α=100.455(3)° β=90.162(2)° γ=101.805(2)°
Cl4Cu7Na2O14Se4
Cl4Cu7Na2O14Se4
Dalton transactions (Cambridge, England : 2003) (2016) 45, 20 8324-8326
a=7.446(2)Å b=8.349(3)Å c=9.137(3)Å
α=110.335(7)° β=106.166(3)° γ=105.161(7)°
C33H39N6O12Tb
C33H39N6O12Tb
ACS applied materials & interfaces (2018) 10, 17 14698-14707
a=16.3738(6)Å b=16.3738(6)Å c=56.467(3)Å
α=90° β=90° γ=120°
CuDy2O12S2
CuDy2O12S2
Crystal Growth & Design (2015) 15, 6 2742
a=6.304(4)Å b=6.663(4)Å c=10.724(6)Å
α=90.00° β=98.527(10)° γ=90.00°
CuH4O12S2Tb2
CuH4O12S2Tb2
Crystal Growth & Design (2015) 15, 6 2742
a=6.321(2)Å b=6.693(2)Å c=10.757(4)Å
α=90.00° β=98.533(7)° γ=90.00°
CuEu2H4O12S2
CuEu2H4O12S2
Crystal Growth & Design (2015) 15, 6 2742
a=6.369(3)Å b=6.760(3)Å c=10.820(4)Å
α=90.00° β=98.600(9)° γ=90.00°
CuH4O12S2Sm2
CuH4O12S2Sm2
Crystal Growth & Design (2015) 15, 6 2742
a=6.393(3)Å b=6.792(3)Å c=10.845(5)Å
α=90.00° β=98.616(9)° γ=90.00°
C12H13BF2O4
C12H13BF2O4
ACS applied materials & interfaces (2014) 6, 4 2279-2284
a=6.9547(11)Å b=8.5168(14)Å c=11.8751(18)Å
α=82.715(13)° β=78.561(13)° γ=67.088(16)°
Cu5Na2O19S3Te
Cu5Na2O19S3Te
Inorganic chemistry (2016) 55, 2 644-648
a=7.294(3)Å b=12.005(4)Å c=9.214(3)Å
α=90.00° β=111.160(6)° γ=90.00°
Cu5K2O19S3Te
Cu5K2O19S3Te
Inorganic chemistry (2016) 55, 2 644-648
a=7.4676(13)Å b=12.1779(13)Å c=9.3974(17)Å
α=90.00° β=111.352(8)° γ=90.00°